UBS OCONNOR LLC - EPIPHANY TECHNOLOGY ACQUISIT ownership

EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHYW and the CUSIP is 29429X117. A total of 60 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of EPIPHANY TECHNOLOGY ACQUISIT
ValueSharesWeighting
Q3 2022$6,000,000
-25.0%
89,342
-9.1%
0.00%
Q2 2022$8,000,000
-93.8%
98,324
-42.6%
0.00%
-100.0%
Q4 2021$128,000,000
-13.5%
171,253
+2.8%
0.00%0.0%
Q3 2021$148,000,000
-20.9%
166,6600.0%0.00%
-50.0%
Q2 2021$187,000,000
+36.5%
166,6600.0%0.00%0.0%
Q1 2021$137,000,000166,6600.00%
Other shareholders
EPIPHANY TECHNOLOGY ACQUISIT shareholders Q1 2022
NameSharesValueWeighting ↓
LH Capital Markets, LLC 1,000,000$337,0000.78%
Cohen & Co Financial Management, LLC 24,628$8,0000.06%
Radcliffe Capital Management, L.P. 199,999$1,964,0000.04%
Q Global Advisors, LLC 147,427$50,0000.03%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,676,514$908,0000.02%
Potrero Capital Research LLC 100,133$34,0000.01%
Arena Capital Advisors, LLC- CA 200,888$68,0000.01%
LMR Partners LLP 66,666$655,0000.01%
Sage Rock Capital Management LP 119,766$40,0000.01%
CANTOR FITZGERALD, L. P. 217,800$74,0000.01%
View complete list of EPIPHANY TECHNOLOGY ACQUISIT shareholders